Incidence of recurrent venous thromboembolism of patients after termination of treatment with ximelagatran

被引：0
|
作者：
Job Harenberg
Ingrid Jörg
Christel Weiss
机构：
[1] University Hospital Mannheim,IV. Department of Medicine
[2] University Hospital Mannheim,Institute for Biometry and Medical Statistics
来源：
European Journal of Clinical Pharmacology | 2006年 / 62卷
关键词：
Follow-up; Low-molecular weight heparin; Venous thromboembolism; Warfarin; Ximelagatran;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：173 / 177
页数：4
相关论文
共 50 条
  • [21] Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism
    Poli, Daniela
    Grifoni, Elisa
    Antonucci, Emilia
    Arcangeli, Chiara
    Prisco, Domenico
    Abbate, Rosanna
    Miniati, Massimo
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 30 (03) : 294 - 299
  • [22] Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism
    Daniela Poli
    Elisa Grifoni
    Emilia Antonucci
    Chiara Arcangeli
    Domenico Prisco
    Rosanna Abbate
    Massimo Miniati
    Journal of Thrombosis and Thrombolysis, 2010, 30 : 294 - 299
  • [23] Incidence of venous thromboembolism in tuberculosis patients
    Ambrosetti, Marco
    Ferrarese, Maurizio
    Codecasa, Luigi Ruffo
    Besozzi, Giorgio
    Sarassi, Antonio
    Viggiani, Piero
    Migliori, Giovanni Battista
    RESPIRATION, 2006, 73 (03) : 396 - 396
  • [24] Incidence of venous thromboembolism in patients with lymphoma
    Conlon, S. J.
    White, R. H.
    Chew, H. K.
    Wun, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 168 - 168
  • [25] Treatment of venous thromboembolism and long-term prevention of recurrence: Present treatment options and ximelagatran
    Eriksson, H
    DRUGS, 2004, 64 (Suppl 1) : 37 - 46
  • [26] The incidence of recurrent venous thromboembolism (VTE) and bleeding depending on practical treatment pattern of anticoagulation in the cancer patients with VTE
    Bang, S-M.
    Kang, J-H.
    Hong, M. H.
    Ahn, J. S.
    Oh, S. Y.
    Baek, J. H.
    Choi, Y. J.
    Shin, S. H.
    Kim, Y-J.
    Cha, J-H.
    Lee, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [27] Pharmacokinetics of melagatran after oral dosing with ximelagatran, a direct thrombin inhibitor, in patients with acute venous thromboembolism (VTE).
    Cullberg, M
    Eriksson, H
    Eriksson, UG
    Frison, L
    Karlsson, MO
    Schulman, S
    Thuresson, A
    Wåhlander, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P61 - P61
  • [28] Incidence of venous thromboembolism after cardiovascular surgery
    Saitoh, Masato
    Kudo, Takemi
    Watanabe, Takao
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2024, 32 (04): : 206 - 212
  • [29] Venous Thromboembolism Incidence After Craniofacial Surgery
    Omesiete, Wilson I.
    Walker, James A., III
    Yu, Jack C.
    ANNALS OF PLASTIC SURGERY, 2018, 80 (05) : 561 - 564
  • [30] Treatment of Venous Thromboembolism and Long-Term Prevention of Recurrence: Present Treatment Options and Ximelagatran
    Henry Eriksson
    Drugs, 2004, 64 : 37 - 46
12345